8-K
Petco Health & Wellness Company, Inc. false 0001826470 0001826470 2021-08-19 2021-08-19

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 19, 2021

 

 

Petco Health and Wellness Company, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-39878   81-1005932

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

10850 Via Frontera

San Diego, California 92127

(Address of Principal Executive Offices)

(858) 453-7845

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Class A common stock, par value $0.001 per share   WOOF   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On August 19, 2021, Petco Health and Wellness Company, Inc. (the “Company”) issued a press release disclosing its financial results for the quarter ended July 31, 2021. The full text of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 7.01. Regulation FD Disclosure.

The Company has scheduled a webcast call at approximately 8:30 a.m. Eastern Time on August 19, 2021 to discuss the Company’s financial results for the quarter ended July 31, 2021. An earnings presentation will be made available on the Company’s investor relations page at ir.petco.com/investor-relations. A replay of the webcast will also be made available on the Company’s investor relations page through September 2, 2021 at 5:00 PM Eastern Time.

The information being furnished pursuant to Item 2.02, including Exhibit 99.1, and Item 7.01 of this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liability of that section, and shall not be incorporated by reference into any other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

   Description
99.1    Press Release, dated August 19, 2021
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

                                       Petco Health and Wellness Company, Inc.
Date: August 19, 2021     By:  

/s/ Ilene Eskenazi

                                           Name: Ilene Eskenazi
    Title: Chief Legal Officer and Corporate Secretary
EX-99.1

LOGO

Exhibit 99.1

 

Contacts:   
Investor Relations    Media Relations
Kristy Moser    Ventura Olvera
Kristine.moser@petco.com    Ventura.olvera@petco.com

FOR IMMEDIATE RELEASE: August 19, 2021

Petco Health + Wellness Company, Inc. announces record revenue and earnings with 20 percent comp growth and 30 percent on a two-year basis

 

   

Recurring revenue offerings, rapidly expanding vet business and digital growth drive eleventh consecutive quarter of comparable sales growth

 

   

Revenue growth of 19 percent year over year and 31 percent on a two-year basis

 

   

Earnings per share of $0.28; Adjusted Earnings Per Share1 of $0.25

 

   

Raised full year 2021 guidance on top and bottom line

San Diego, August 19, 2021 – Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today released its financial results for its second quarter ended July 31, 2021.

In the second quarter of 2021, Petco delivered net revenue of $1.4 billion, up 19 percent versus prior year. Net income improved by $67.7 million from prior year to $75.1 million or $0.28 per share. Trailing twelve month net income improved by $139.0 million from prior year to $79.9 million. Adjusted Net Income1 increased $44.4 million from prior year to $67.5 million or $0.25 per share, while second quarter Adjusted EBITDA1 increased by 19 percent from prior year to $155.1 million.

“With purpose driven performance at the heart of all we do, our second quarter results reflect the strength of our differentiated model and continued focus on driving customer acquisition, increasing spend, fueling comp growth of 20 percent year-over-year and 30 percent on a two-year stack,” said Ron Coughlin, Chairman and Chief Executive Officer of Petco. “We exited Q2 with strong momentum while lapping robust double-digit comp growth. Looking ahead, we’re operating from a position of strength as we move into the second half, which gave us the confidence to raise our guidance. We believe we have significant runway for continued growth as we execute against our proven transformation strategy in multi-year growth areas across services, veterinary care, digital, and owned and premium brands.”

Additionally, in the first half of 2021 total debt remained roughly flat at $1.7 billion with Net Debt1 improving $73.4 million to $1.5 billion driven by net cash flow from operations of $202.4 million and Free Cash Flow1 of $102.5 million, up 119 percent and 142 percent, respectively, from the first half of 2020. Also in the first half of 2021, Net Debt1 / Trailing Twelve Month Adjusted EBITDA1 decreased 16 percent or 0.5x to 2.7x driven by Free Cash Flow1 generation and growth in Adjusted EBITDA1.

 

-1-


Fiscal Q2 2021 Highlights:

Comparisons are second quarter of 2021 ended July 31, 2021 versus second quarter of 2020 ended August 1, 2020 unless otherwise noted

 

   

Net revenue increased 19 percent to $1.4 billion driven by comp sales growth of 20 percent

 

   

Net income increased $67.7 million to $75.1 million or $0.28 per share

 

   

Adjusted Net Income1 increased $44.4 million to $67.5 million or $0.25 per share

 

   

Adjusted EBITDA1 increased 19 percent to $155.1 million, excluding a $45.2 million gain from mark to market on our investment in A Place for Rover, Inc4

 

   

Trailing twelve month net income increased $139.0 million to $79.9 million

 

   

Trailing Twelve Month Adjusted EBITDA increased $98.2 million to $547.5 million

 

   

Net cash provided by operating activities increased $110.0 million to $202.4 million in the first half of the 2021

 

   

Free Cash Flow1 increased $60.2 million to $102.5 million in the first half of 2021

 

   

Total debt decreased $1.6 billion or 49 percent to $1.7 billion driven by the proceeds generated in the company’s initial public offering, related recapitalization, and Free Cash Flow1 generation

 

   

Net Debt1 decreased $1.6 billion or 52 percent to $1.5 billion

 

   

Net Debt1 / Trailing Twelve Month Adjusted EBITDA1 improved 61 percent to 2.7x

 

   

Liquidity of $644.5 million inclusive of $203.4 million of cash and cash equivalents and $441.1 million of availability on revolving credit facility

 

   

Ended the quarter with 1,451 Pet Care Centers, 155 Full Service Vet Hospitals within Pet Care Centers, and 101 Pet Care Centers in Mexico

Fiscal 2021 Guidance:

The following guidance as of August 19, 2021 reflects the company’s expectations for fiscal year 2021 unless otherwise indicated.

 

Metric

   Current Guidance    Prior Guidance

Net Revenue

   $5.6 billion-$5.7 billion    $5.475 billion-$5.575 billion

Adjusted EBITDA2

   $565 million-$575 million    $550 million-$560 million

Adjusted EPS2

   $0.81-$0.85    $0.73-$0.76

Capital Expenditures3

   Near top of prior range    $185 million-$235 million

Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. The company continues to monitor those assumptions and any potential financial impacts. Adjusted EPS guidance assumes approximately $80 million of interest expense, a 26 percent tax rate and 266 million weighted average diluted share count.

 

(1)

Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow, Net Debt, and Trailing Twelve Month Adjusted EBITDA are non-GAAP financial measures. See “Non-GAAP Financial Measures” for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

(2)

We have not reconciled Adjusted EBITDA and Adjusted EPS outlook as non-GAAP measures to the most comparable GAAP measures because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management’s control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlooks for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are estimated in a manner consistent with the relevant definitions and assumptions noted herein.

(3)

Original capital expenditure guidance was given in the 10-K.

 

-2-


(4)

In July 2021, the company recognized a $45.2 million gain from the remeasurement of the fair value of its investment in A Place for Rover, Inc. (“Rover”) following Rover’s completion of a business combination with Nebula Caravel Acquisition Corp., a publicly-traded special purpose acquisition company.

Earnings Conference Call Webcast Information:

The company will host an earnings conference call on August 19, 2021 at 8:30 AM Eastern Time to discuss Petco’s financial results. The conference call will be accessible through live webcast. Interested investors and other individuals can access the webcast, earnings press release, and earnings presentation via the company’s investor relations page at ir.petco.com/investor-relations. A replay of the webcast will be archived on the company’s website through September 2, 2021 at 5:00 PM Eastern Time.

About Petco, The Health + Wellness Co.:

Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding in 1965, we’ve been striving to set new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 Petco locations across the U.S., Mexico and Puerto Rico, including a growing network of more than 150 in-store veterinary hospitals, and offer a complete online resource for pet health and wellness at petco.com and on the Petco app. In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we’ve helped find homes for more than 6.5 million animals.

Forward-Looking Statements:

This earnings release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our environmental and other sustainability plans and goals, and potential acquisitions, investments and dispositions. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct. There can be no assurance that any forward-looking results will occur or be realized, and nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. Such forward-looking statements can be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “intends,” “will,” “shall,” “should,” “anticipates,” “opportunity,” “illustrative”, or the negative thereof or other variations thereon or comparable terminology. All forward-looking statements are based on assumptions or judgments about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-

 

-3-


looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from the potential results discussed in the forward-looking statements, including, without limitation, those identified in this earnings release, the risk factors that Petco identifies in its Securities and Exchange Commission filings, as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a privacy or security breach; (x) our ability to effectively manage strategic ventures, alliances or acquisitions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) interruptions and other supply chain issues; (xiii) catastrophic events, health crises, and pandemics, including the potential effects that the ongoing COVID-19 pandemic and/or corresponding macroeconomic uncertainty could have on our financial position, results of operations and cash flows; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; and (xix) changes in our credit ratings. The occurrence of any such factors, events, or circumstances would significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of important factors is not complete, and any forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any forward-looking statement that it may make, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

 

-4-


PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)

 

     13 Weeks Ended  
     July 31,
2021
    August 1,
2020
    Percent
Change
 

Net sales

   $  1,434,534     $  1,208,971       19

Cost of sales

     835,124       679,218       23
  

 

 

   

 

 

   

 

 

 

Gross profit

     599,410       529,753       13

Selling, general and administrative expenses

     525,942       464,706       13
  

 

 

   

 

 

   

 

 

 

Operating income

     73,468       65,047       13

Interest income

     (13     (99     (87 %) 

Interest expense

     19,206       54,493       (65 %) 

Other non-operating income

     (45,162     —         N/M  
  

 

 

   

 

 

   

 

 

 

Income before income taxes and income from equity method investees

     99,437       10,653       833

Income tax expense

     27,011       4,958       445

Income from equity method investees

     (2,429     (745     226
  

 

 

   

 

 

   

 

 

 

Net income

     74,855       6,440       1062

Net loss attributable to noncontrolling interest

     (256     (1,001     (74 %) 
  

 

 

   

 

 

   

 

 

 

Net income attributable to Class A and B-1 common stockholders

   $ 75,111     $ 7,441       909

Net income per Class A and B-1 common share:

      

Basic

   $ 0.28     $ 0.04       699

Diluted

   $ 0.28     $ 0.04       696

Weighted average shares used in computing net income per Class A and B-1 common share:

      

Basic

     264,216       209,015       26

Diluted

     265,217       209,015       27

 

-5-


PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Q2 2021 unaudited and subject to reclassification)

 

     July 31,
2021
    January 30,
2021
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 203,404     $ 111,402  

Receivables, less allowance for credit losses1

     39,889       41,827  

Merchandise inventories, net

     628,491       538,675  

Prepaid expenses

     41,990       40,032  

Other current assets

     30,381       45,613  
  

 

 

   

 

 

 

Total current assets

     944,155       777,549  
  

 

 

   

 

 

 

Fixed assets

     1,586,677       1,487,987  

Less accumulated depreciation

     (932,283     (860,440
  

 

 

   

 

 

 

Fixed assets, net

     654,394       627,547  

Operating lease right-of-use assets

     1,314,533       1,328,108  

Goodwill

     2,182,465       2,179,310  

Trade name

     1,025,000       1,025,000  

Other intangible assets

     4,793       4,793  

Less accumulated amortization

     (4,251     (4,079
  

 

 

   

 

 

 

Other intangible assets, net

     542       714  

Other long-term assets

     194,092       137,474  
  

 

 

   

 

 

 

Total assets

   $  6,315,181     $  6,075,702  
  

 

 

   

 

 

 

LIABILITIES AND EQUITY

    

Current liabilities:

    

Accounts payable and book overdrafts

   $ 406,685     $ 339,485  

Accrued salaries and employee benefits

     123,721       129,484  

Accrued expenses and other liabilities

     210,517       145,846  

Current portion of operating lease liabilities

     248,631       258,289  

Current portion of long-term debt and other lease liabilities

     20,235       2,203  
  

 

 

   

 

 

 

Total current liabilities

     1,009,789       875,307  
  

 

 

   

 

 

 

Senior secured credit facilities, net, excluding current portion

     1,646,463       1,646,281  

Operating lease liabilities, excluding current portion

     1,070,063       1,083,575  

Deferred taxes, net

     293,611       280,920  

Other long-term liabilities

     135,873       134,354  
  

 

 

   

 

 

 

Total liabilities

     4,155,799       4,020,437  
  

 

 

   

 

 

 

Commitments and contingencies

    

Stockholders’ equity:

    

Class A common stock2

     226       226  

Class B-1 common stock3

     38       38  

Class B-2 common stock4

     —         —    

Preferred stock5

     —         —    

Additional paid-in-capital

     2,115,220       2,092,110  

Retained earnings (accumulated deficit)

     60,420       (22,251

Accumulated other comprehensive loss

     (1,272     (1,275
  

 

 

   

 

 

 

Total stockholders’ equity

     2,174,632       2,068,848  
  

 

 

   

 

 

 

Noncontrolling interest

     (15,250     (13,583
  

 

 

   

 

 

 

Total equity

     2,159,382       2,055,265  
  

 

 

   

 

 

 

Total liabilities and equity

   $ 6,315,181     $ 6,075,702  
  

 

 

   

 

 

 

 

(1)

Allowances for credit losses are $1,802 as of July 31, 2021 and $3,267 as of Jan 30, 2021

(2)

Class A common stock, par value $0.001 per share (1.0 billion shares authorized and 226.5 million shares issued and outstanding as of July 31, 2021 and 226.4 million shares issued and outstanding as of January 30, 2021)

(3)

Class B-1 common stock, par value $0.001 per share (75.0 million shares authorized and 37.8 million shares issued and outstanding)

(4)

Class B-2 common stock, par value $0.000001 per share (75.0 million shares authorized and 37.8 million shares issued and outstanding)

(5)

Preferred stock, par value $0.001 per share (25.0 million shares authorized and no shares issued or outstanding)

 

-6-


PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)

 

     26 Weeks Ended  
     July 31,
2021
    August 1,
2020
 

Cash flows from operating activities:

    

Net income (loss)

   $ 81,004     $ (26,932

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

    

Depreciation and amortization

     82,845       86,038  

Amortization of debt discounts and issuance costs

     3,369       12,125  

Provision for deferred taxes

     12,691       (21,753

Equity-based compensation

     23,110       4,617  

Impairments, write-offs and losses on sale of fixed and other assets

     2,690       6,261  

Loss on extinguishment and modification of debt

     20,838       —    

Income from equity method investees

     (4,854     (1,077

Amounts reclassified out of accumulated other comprehensive income

     —         5,066  

Change in contingent consideration obligation

     —         (391

Non-cash operating lease costs

     210,490       216,729  

Other non-operating income

     (45,162     —    

Changes in assets and liabilities:

    

Receivables

     1,937       (5,208

Merchandise inventories

     (89,784     (11,056

Prepaid expenses and other assets

     3,294       (9,153

Accounts payable and book overdrafts

     74,466       (18,955

Accrued salaries and employee benefits

     (6,017     3,116  

Accrued expenses and other liabilities

     51,145       35,747  

Operating lease liabilities

     (220,655     (196,700

Other long-term liabilities

     997       13,915  
  

 

 

   

 

 

 

Net cash provided by operating activities

     202,404       92,389  
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Cash paid for fixed assets

     (99,883     (50,043

Cash paid for acquisitions, net of cash acquired

     (2,807     —    

Distributions from equity investees

     —         73  

Proceeds from sale of assets

     105       1,296  
  

 

 

   

 

 

 

Net cash used in investing activities

     (102,585     (48,674
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Borrowings under long-term debt agreements

     1,700,000       440,000  

Repayments of long-term debt

     (1,682,361     (456,625

Debt refinancing costs and original issue discount

     (24,665     —    

Payments for finance lease liabilities

     (2,044     (2,089

Proceeds from employee stock purchase plan

     1,721       —    

Repurchase of equity

     —         (105

Payment of contingent consideration

     —         (250

Payment of offering costs

     (3,844     —    
  

 

 

   

 

 

 

Net cash used in financing activities

     (11,193     (19,069
  

 

 

   

 

 

 

Net increase in cash, cash equivalents and restricted cash

     88,626       24,646  

Cash, cash equivalents and restricted cash at beginning of period

     119,540       154,718  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash at end of period

   $ 208,166     $ 179,364  
  

 

 

   

 

 

 

 

-7-


NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in the earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the earnings release. The non-GAAP financial measures in the earnings release may differ from similarly titled measures used by other companies.

Adjusted EBITDA

Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in net income (loss) calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it best allows comparison of the current period performance with that of the comparable period. In addition, Adjusted EBITDA affords investors a view of what management considers Petco’s operating performance to be as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period.

Please see the company’s 10-K filed on April 5, 2021 for additional information on the reconciliation of Net Income (Loss) Attributable to Class A and B-1 Common Stockholders to Adjusted EBITDA. The tables below reflect the calculation of Adjusted EBITDA for the thirteen weeks and trailing twelve months ended July 31, 2021 compared to the prior year quarter and twelve-month period ended August 1, 2020, respectively, as well as the twelve month period ended January 30, 2021.

 

-8-


(Dollars in thousands)    13 Weeks Ended  
Reconciliation of Net Income Attributable to Class A and B-1
Common Stockholders to Adjusted EBITDA
   July 31,
2021
    August 1,
2020
 

Net income attributable to Class A and B-1 common stockholders

   $ 75,111     $ 7,441  

Add (deduct):

    

Interest expense, net

     19,193       54,394  

Income tax expense

     27,011       4,958  

Depreciation and amortization

     41,238       42,471  

Income from equity method investees

     (2,429     (745

Asset impairments and write offs

     1,743       2,852  

Equity-based compensation

     11,506       2,312  

Other non-operating income

     (45,162     —    

Mexico joint venture EBITDA (1)

     5,856       3,483  

Store pre-opening expenses

     3,488       1,477  

Store closing expenses

     962       2,609  

Non-cash occupancy-related costs (2)

     2,885       5,969  

Non-recurring costs (3)

     13,671       3,591  
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 155,073     $ 130,812  
  

 

 

   

 

 

 

Net sales

   $ 1,434,534     $ 1,208,971  

Net margin (4)

     5.2     0.6

Adjusted EBITDA Margin

     10.8     10.8

 

(Dollars in thousands)    Trailing Twelve Months  
Reconciliation of Net Income (Loss) Attributable to Class A and B-1
Common Stockholders to Adjusted EBITDA
   July 31,
2021
    January 30,
2021
    August 1,
2020
 

Net income (loss) attributable to Class A and B-1 common stockholders

   $ 79,915     $ (26,483)     $ (59,117)  

Add (deduct):

      

Interest expense, net

     143,113       218,430       238,799  

Income tax expense (benefit)

     31,950       (3,337     (21,439

Depreciation and amortization

     171,643       174,836       173,968  

Income from equity method investees

     (10,259     (6,482     (3,080

Loss on debt extinguishment and modification

     38,387       17,549       —    

Goodwill & indefinite-lived intangible impairment

     —         —         19,000  

Asset impairments and write offs

     12,035       15,606       12,448  

Equity-based compensation

     31,408       12,915       9,854  

Other non-operating income

     (45,162     —         —    

Mexico joint venture EBITDA (1)

     23,434       19,074       15,582  

Store pre-opening expenses

     13,360       9,228       8,257  

Store closing expenses

     6,211       7,782       7,110  

Non-cash occupancy-related costs (2)

     10,095       19,240       26,684  

Non-recurring costs (3)

     41,389       25,990       21,285  
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 547,519     $ 484,348     $ 449,351  
  

 

 

   

 

 

   

 

 

 

Net sales

   $ 5,447,238     $ 4,920,202     $ 4,564,217  

Net margin (4)

     1.5     (0.5 %)      (1.3 %) 

Adjusted EBITDA Margin

     10.1     9.8     9.8

 

-9-


Adjusted Net Income and Adjusted EPS

Adjusted Net Income and Adjusted diluted earnings per share attributable to Petco (Adjusted Net Income and Adjusted EPS respectively) are considered non-GAAP financial measures under the SEC’s rules because they exclude certain amounts included in the net income (loss) attributable to common stockholders and diluted earnings per share attributable to Petco calculated in accordance with GAAP (net income (loss) and EPS respectively), the most directly comparable financial measures calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they best allow comparison of the current period performance with that of the comparable period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers Petco’s earnings performance to be as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

The tables below reflect the calculation of Adjusted Net Income (Loss) and Adjusted EPS for the thirteen weeks ended July 31, 2021 compared to the prior year quarter ended August 1, 2020.

 

(In thousands, except per share amounts)    13 Weeks Ended  
Reconciliation of Diluted EPS to Adjusted EPS    July 31, 2021      August 1, 2020  
     Amount      Per share      Amount      Per share  

Net income attributable to common stockholders / diluted EPS

   $ 75,111      $ 0.28      $ 7,441      $ 0.04  

Add (deduct):

           

Income tax expense

     27,011        0.10        4,958        0.02  

Asset impairments and write offs

     1,743        0.01        2,852        0.01  

Equity-based compensation

     11,506        0.04        2,312        0.01  

Other non-operating income

     (45,162      (0.17      —          —    

Store pre-opening expenses

     3,488        0.01        1,477        0.01  

Store closing expenses

     962        0.01        2,609        0.01  

Non-cash occupancy-related costs (2)

     2,885        0.01        5,969        0.03  

Non-recurring costs (3)

     13,671        0.05        3,591        0.02  
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted pre-tax income / diluted earnings per share

   $ 91,215      $ 0.34      $ 31,209      $ 0.15  

Income tax expense at 26% normalized tax rate

     23,716        0.09        8,114        0.04  
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted Net Income / Adjusted EPS

   $ 67,499      $ 0.25      $ 23,095      $ 0.11  
  

 

 

    

 

 

    

 

 

    

 

 

 

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash generated by operations less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company’s financial performance.

Although other companies report their Free Cash Flow, numerous methods exist for calculating a company’s Free Cash Flow. As a result, the method used by Petco’s management to calculate Free Cash Flow may differ from the methods used by other companies to calculate their Free Cash Flow.

The following table sets forth a reconciliation of Free Cash Flow to net cash provided by (used in) operating activities, which Petco believes to be the GAAP financial measure most directly comparable to Free Cash Flow. The table below reflects the calculation of Free Cash Flow for the thirteen and twenty six weeks ended July 31, 2021 compared to the thirteen and twenty six weeks ended August 1, 2020.

 

(in thousands)    13 Weeks Ended      26 Weeks Ended  
     July 31,
2021
     August 1,
2020
     July 31,
2021
     August 1,
2020
 

Net cash provided by operating activities

   $ 87,402      $ 124,678      $ 202,404      $ 92,389  

Cash paid for fixed assets

     (52,532      (22,148      (99,883      (50,043
  

 

 

    

 

 

    

 

 

    

 

 

 

Free Cash Flow

   $ 34,870      $ 102,530      $ 102,521      $ 42,346  

 

-10-


Net Debt

Net Debt is a non-GAAP financial measure that is calculated as the sum of current and non-current debt, less cash and cash equivalents. Management considers this adjustment useful because it reduces the volatility of total debt caused by fluctuations between cash paid against the company’s revolving credit facility and cash held on hand in cash and cash equivalents.

Although other companies report their Net Debt, numerous methods exist for calculating a company’s Net Debt. As a result, the method used by Petco’s management to calculate Net Debt may differ from the methods used by other companies to calculate their Net Debt.

The following table sets forth a reconciliation of Net Debt, to total debt, which Petco believes to be the GAAP financial measure most directly comparable to Net Debt. The table below reflects the calculation of Net Debt as of the period ended July 31, 2021 compared to the prior quarters ended January 30, 2021 and August 1, 2020.

 

(Dollars in thousands)    July 31,
2021
     January 30,
2021
     August 1,
2020
 

Total debt:

        

Senior secured credit facilities, net, including current portion

   $ 1,663,463      $ 1,646,281      $ 2,381,419  

Senior notes, net

     —          —          867,778  

Finance leases, including current portion

     15,104        13,639        14,347  
  

 

 

    

 

 

    

 

 

 

Total debt

     1,678,567        1,659,920        3,263,544  

Less: cash and cash equivalents

     (203,404      (111,402      (168,892
  

 

 

    

 

 

    

 

 

 

Net Debt

   $ 1,475,163      $ 1,548,518      $ 3,094,652  
  

 

 

    

 

 

    

 

 

 

Adjusted EBITDA (TTM)

   $ 547,519      $ 484,348      $ 449,351  

Net Debt / Adjusted EBITDA ratio

     2.7x        3.2x        6.9x  

 

-11-


Adjusted EBITDA, Adjusted Net Income and Adjusted EPS Footnotes

 

(1)

Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company’s Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.

 

     13 Weeks Ended  
(In thousands)    July 31,
2021
     August 1,
2020
 

Net income

   $ 4,864      $ 2,384  

Depreciation

     3,401      $ 2,702  

Income tax expense

     2,631      $ 1,129  

Foreign currency gain

     (342    $ (295

Interest expense, net

     1,158      $ 1,046  
  

 

 

    

 

 

 

EBITDA

   $ 11,712      $ 6,966  
  

 

 

    

 

 

 

50% of EBITDA

   $ 5,856      $ 3,483  
  

 

 

    

 

 

 

 

(2)

Non-cash occupancy-related costs include the difference between cash and straight-line rent for all periods.

(3)

Non-recurring costs include: severance; legal reserves and related fees; one-time consulting and other costs associated with our strategic transformation initiatives; discontinuation and liquidation costs; and costs related to the initial public offering and refinancing. While we incurred significant costs associated with the COVID-19 pandemic during fiscal 2020, we have not classified any of these costs as non-recurring due to the uncertainty surrounding the pandemic’s length and long-term impact on the macroeconomic operating environment.

(4)

We define net margin as net income (loss) attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

WOOF-F

 

-12-